These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 12694585)
1. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome. Quelvennec E; Bera O; Cabre P; Alizadeh M; Smadja D; Jugde F; Edan G; Semana G Tissue Antigens; 2003 Feb; 61(2):166-71. PubMed ID: 12694585 [TBL] [Abstract][Full Text] [Related]
2. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164 [TBL] [Abstract][Full Text] [Related]
3. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Allen M; Sandberg-Wollheim M; Sjögren K; Erlich HA; Petterson U; Gyllensten U Hum Immunol; 1994 Jan; 39(1):41-8. PubMed ID: 8181961 [TBL] [Abstract][Full Text] [Related]
4. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Lincoln MR; Ramagopalan SV; Chao MJ; Herrera BM; Deluca GC; Orton SM; Dyment DA; Sadovnick AD; Ebers GC Proc Natl Acad Sci U S A; 2009 May; 106(18):7542-7. PubMed ID: 19380721 [TBL] [Abstract][Full Text] [Related]
5. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients. Amirzargar A; Mytilineos J; Yousefipour A; Farjadian S; Scherer S; Opelz G; Ghaderi A Eur J Immunogenet; 1998 Aug; 25(4):297-301. PubMed ID: 9777330 [TBL] [Abstract][Full Text] [Related]
6. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP). Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121 [TBL] [Abstract][Full Text] [Related]
7. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel. Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697 [TBL] [Abstract][Full Text] [Related]
8. Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population. Deschamps R; Paturel L; Jeannin S; Chausson N; Olindo S; Béra O; Bellance R; Smadja D; Césaire D; Cabre P Mult Scler; 2011 Jan; 17(1):24-31. PubMed ID: 20861181 [TBL] [Abstract][Full Text] [Related]
9. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice. Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275 [TBL] [Abstract][Full Text] [Related]
10. TAP2 polymorphisms in Australian multiple sclerosis patients. Bennetts BH; Teutsch SM; Heard RN; Dunckley H; Stewart GJ J Neuroimmunol; 1995 Jun; 59(1-2):113-21. PubMed ID: 7797612 [TBL] [Abstract][Full Text] [Related]
11. HLA class I and class II allele and haplotype diversity in Martinicans. Bera O; Cesaire R; Quelvennec E; Quillivic F; de Chavigny V; Ribal C; Semana G Tissue Antigens; 2001 Mar; 57(3):200-7. PubMed ID: 11285127 [TBL] [Abstract][Full Text] [Related]
12. HLA-DR and -DQ associations with multiple sclerosis in Turkey. Saruhan-Direskeneli G; Esin S; Baykan-Kurt B; Ornek I; Vaughan R; Eraksoy M Hum Immunol; 1997 Jun; 55(1):59-65. PubMed ID: 9328791 [TBL] [Abstract][Full Text] [Related]
13. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients. Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150 [TBL] [Abstract][Full Text] [Related]
14. HLA class II polymorphism in Latin American patients with multiple sclerosis. Rojas OL; Rojas-Villarraga A; Cruz-Tapias P; Sánchez JL; Suárez-Escudero JC; Patarroyo MA; Anaya JM Autoimmun Rev; 2010 Apr; 9(6):407-13. PubMed ID: 19896562 [TBL] [Abstract][Full Text] [Related]
15. DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians. Caballero A; Alvés-León S; Papais-Alvarenga R; Fernández O; Navarro G; Alonso A Tissue Antigens; 1999 Nov; 54(5):524-6. PubMed ID: 10599893 [TBL] [Abstract][Full Text] [Related]
16. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Marrosu MG; Murru R; Murru MR; Costa G; Zavattari P; Whalen M; Cocco E; Mancosu C; Schirru L; Solla E; Fadda E; Melis C; Porru I; Rolesu M; Cucca F Hum Mol Genet; 2001 Dec; 10(25):2907-16. PubMed ID: 11741834 [TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Fogdell-Hahn A; Ligers A; Grønning M; Hillert J; Olerup O Tissue Antigens; 2000 Feb; 55(2):140-8. PubMed ID: 10746785 [TBL] [Abstract][Full Text] [Related]
18. Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Petrone A; Giorgi G; Mesturino CA; Capizzi M; Cascino I; Nistico L; Osborn J; Di Mario U; Buzzetti R Thyroid; 2001 Feb; 11(2):171-5. PubMed ID: 11288988 [TBL] [Abstract][Full Text] [Related]
19. HLA-DRB1 and HLA-DQB1 genes in susceptibility and resistance to cicatricial pemphigoid in French Caucasians. Drouet M; Delpuget-Bertin N; Vaillant L; Chauchaix S; Boulanger MD; Bonnetblanc JM; Bernard P Eur J Dermatol; 1998; 8(5):330-3. PubMed ID: 9683867 [TBL] [Abstract][Full Text] [Related]
20. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population. Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]